
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SphK1 promotes development of non‑small cell lung cancer through activation of STAT3
Yuefeng Ma, Xin Xing, Ranran Kong, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 374-386
Open Access | Times Cited: 29
Yuefeng Ma, Xin Xing, Ranran Kong, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 374-386
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 44
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 44
Lung cancer metabolomics: a pooled analysis in the Cancer Prevention Studies
Ziyin Tang, Donghai Liang, Emily L. Deubler, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Ziyin Tang, Donghai Liang, Emily L. Deubler, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway
Kai Teng, Hanlin Ma, Panpan Gai, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Kai Teng, Hanlin Ma, Panpan Gai, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth
Yuhang Xue, Kanqiu Jiang, Li Ou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 27
Yuhang Xue, Kanqiu Jiang, Li Ou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 27
The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620
Jianhua Zha, Yingchen Xia, Chun-lin Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Jianhua Zha, Yingchen Xia, Chun-lin Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29
Nanoparticle co-delivery of carboplatin and PF543 restores platinum sensitivity in ovarian cancer models through inhibiting platinum-induced pro-survival pathway activation
Chen Wang, Qing Li, Keqi Song, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 16, pp. 4082-4093
Open Access | Times Cited: 4
Chen Wang, Qing Li, Keqi Song, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 16, pp. 4082-4093
Open Access | Times Cited: 4
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
Zihan Song, Zijun Zhao, Xuehua Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Zihan Song, Zijun Zhao, Xuehua Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma
Andreea Corina Luca, Margarita Kurnaeva, Daniel John, et al.
Cancer Letters (2025), pp. 217733-217733
Closed Access
Andreea Corina Luca, Margarita Kurnaeva, Daniel John, et al.
Cancer Letters (2025), pp. 217733-217733
Closed Access
Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells
Albena Momchilova, Roumen Pankov, Galya Staneva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10870-10870
Open Access | Times Cited: 16
Albena Momchilova, Roumen Pankov, Galya Staneva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10870-10870
Open Access | Times Cited: 16
Pharmacological Effects of FTY720 and its Derivatives
Mengyuan Han, Xiangran Liu, Sendaer Hailati, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 3, pp. 192-200
Closed Access | Times Cited: 3
Mengyuan Han, Xiangran Liu, Sendaer Hailati, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 3, pp. 192-200
Closed Access | Times Cited: 3
Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
Mengmeng Lin, Yingying Li, Shiyuan Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 14
Mengmeng Lin, Yingying Li, Shiyuan Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 14
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
Zhoujun Lin, Yin Li, Xiao Han, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12741-12741
Open Access | Times Cited: 11
Zhoujun Lin, Yin Li, Xiao Han, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12741-12741
Open Access | Times Cited: 11
SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs
Mengsi Yu, Song Wang, Yujie Zeng, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Mengsi Yu, Song Wang, Yujie Zeng, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Integration of the bulk transcriptome and single-cell transcriptome reveals efferocytosis features in lung adenocarcinoma prognosis and immunotherapy by combining deep learning
Yiluo Xie, Huili Chen, Xueying Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yiluo Xie, Huili Chen, Xueying Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1
Xin Peng, Xiaoli Liu, Wanshan Hu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Xin Peng, Xiaoli Liu, Wanshan Hu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
Ling‐Wei Hii, Felicia Fei‐Lei Chung, Chun‐Wai Mai, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 14
Ling‐Wei Hii, Felicia Fei‐Lei Chung, Chun‐Wai Mai, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 14
TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation
Houqing Yin, Zequn Wang, Dan Wang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175883-175883
Open Access | Times Cited: 5
Houqing Yin, Zequn Wang, Dan Wang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175883-175883
Open Access | Times Cited: 5
RETRACTED ARTICLE: Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis
Zhipeng Ge, Haibo Liu, Tao Ji, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 1276-1287
Open Access | Times Cited: 12
Zhipeng Ge, Haibo Liu, Tao Ji, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 1276-1287
Open Access | Times Cited: 12
Identification and immunological characteristics of anoikis-associated molecular clusters in lung adenocarcinoma
Shuyan He, Xinru Xiao, Chenglong Ma, et al.
Experimental Cell Research (2024) Vol. 438, Iss. 1, pp. 114037-114037
Open Access | Times Cited: 1
Shuyan He, Xinru Xiao, Chenglong Ma, et al.
Experimental Cell Research (2024) Vol. 438, Iss. 1, pp. 114037-114037
Open Access | Times Cited: 1
Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
Xinyan Li, Yixiao Yuan, Mintu Pal, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Xinyan Li, Yixiao Yuan, Mintu Pal, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Sphk1 deficiency induces apoptosis and developmental defects and premature death in zebrafish
Ling Huang, Fang Han, Ying Huang, et al.
Fish Physiology and Biochemistry (2023) Vol. 49, Iss. 4, pp. 737-750
Closed Access | Times Cited: 3
Ling Huang, Fang Han, Ying Huang, et al.
Fish Physiology and Biochemistry (2023) Vol. 49, Iss. 4, pp. 737-750
Closed Access | Times Cited: 3
The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents
Gabriel da Silva, Thaís Moré Milan, Andréia Machado Leopoldino
Gene (2023) Vol. 897, pp. 148063-148063
Closed Access | Times Cited: 2
Gabriel da Silva, Thaís Moré Milan, Andréia Machado Leopoldino
Gene (2023) Vol. 897, pp. 148063-148063
Closed Access | Times Cited: 2
Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma
Zi-Hao Wang, Yu Li, Pei Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 5
Zi-Hao Wang, Yu Li, Pei Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 5
DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas
Noboru Tsuda, Ying Tian, Mao Fujimoto, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 8, pp. 5109-5125
Open Access | Times Cited: 3
Noboru Tsuda, Ying Tian, Mao Fujimoto, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 8, pp. 5109-5125
Open Access | Times Cited: 3
SPHK1 promotes the migration and invasion of gastric cancer cells through NF-κB pathway
Qianlong Ling, Kai Ji, Jiajia Guan, et al.
Research Square (Research Square) (2024)
Open Access
Qianlong Ling, Kai Ji, Jiajia Guan, et al.
Research Square (Research Square) (2024)
Open Access